Cabozantinib original manufacturer and latest price

Cabozantinib (Cabozantinib) is a targeted drug that has attracted much attention worldwide. Its research and development background comes from the in-depth research of the American Exelixis biopharmaceutical company. This drug has shown remarkable therapeutic effects in the field of anti-cancer, especially in controlling cancer bone metastasis, and has been highly praised by the medical community and patients.

After rigorous clinical trials and evaluation, cabozantinib has been successfully approved by the U.S.FDA for the treatment of patients with advanced medullary thyroid cancer and advanced renal cancer. This landmark development provides patients with both types of cancer with new treatment options and greater hope for treatment.

However, for many patients, the high price of cabozantinib’s original drug has become a problem for them to receive treatment. Taking the European market as an example, whether it is COMETRIQ capsules or CABOMETYX tablets, their prices are as high as more than 40,000 yuan per box. Such a price is undoubtedly a huge financial burden for patients who require long-term drug treatment.

Fortunately, with the continuous advancement of medical technology and the increasingly open global market, patients now have more choices. Generic cabozantinib drugs in overseas markets have gradually become favored by patients for their more affordable prices and good quality. Among them, the Lao Lucius version of cabozantinib tablets has become a popular choice in the market with its specifications of 20mg*90 tablets per box and a price of only more than 800 yuan.

Of course, in addition to the Lao Lucius version, there are many other generic versions of cabozantinib on the market, such as the Lao United version, the Bangladesh Yaopin International version, and the IndianNATCO version. These versions vary in price, size and packaging, providing patients with more diverse choices.

Patients should exercise caution when choosing a generic drug. It is recommended to purchase through formal channels and check the packaging, labels, anti-counterfeiting signs and other information of the drugs in detail to ensure the authenticity and effectiveness of the drugs purchased. At the same time, during use, patients should strictly follow the doctor's medication instructions, pay attention to changes in physical condition, and promptly report any discomfort or abnormal reactions to the doctor.

In general, cabozantinib is a broad-spectrum anti-cancer drug with significant efficacy, and the existence of its original drug and generic drugs provides patients with more treatment options.